TRACON Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2014
Total raised
- $41M
Investors
- 8
About TRACON Pharmaceuticals
TRACON Pharmaceuticals Inc.TRACON Pharmaceuticals Inc. specializes in developing therapies for oncology, founded in 2006 and headquartered in San Diego, US.08 mn.TRACON Pharmaceuticals, Inc. is engaged in developing and commercializing innovative cancer therapies through targeted biologics designed to selectively target cancerous cells. Their product offerings include investigational therapeutics aimed at addressing unmet medical needs in oncology, focusing on specific genetic markers or tumor types.In 2023, TRACON Pharmaceuticals, Inc.TRACON Pharmaceuticals plans to advance its pipeline of targeted therapies, with specific product launches aimed at addressing additional oncology indications expected in the coming years. The company is also focused on expanding its market presence into Europe and Asia by 2025, aiming to reach new patient populations.00 mn will support these initiatives as they look to strengthen their product development and market access strategies.
Who invested in TRACON Pharmaceuticals
8 investors across 2 rounds
See all investors in TRACON Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TRACON Pharmaceuticals
Who invested in TRACON Pharmaceuticals?
TRACON Pharmaceuticals has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TRACON Pharmaceuticals raised?
TRACON Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TRACON Pharmaceuticals last raise money?
TRACON Pharmaceuticals's most recent round on record is a Series B, in Sep 2014.
What does TRACON Pharmaceuticals do?
TRACON Pharmaceuticals is a biotechnology company.
Where is TRACON Pharmaceuticals headquartered?
TRACON Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like TRACON Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TRACON Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TRACON Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.